ATE253357T1 - Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika - Google Patents
Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutikaInfo
- Publication number
- ATE253357T1 ATE253357T1 AT98939311T AT98939311T ATE253357T1 AT E253357 T1 ATE253357 T1 AT E253357T1 AT 98939311 T AT98939311 T AT 98939311T AT 98939311 T AT98939311 T AT 98939311T AT E253357 T1 ATE253357 T1 AT E253357T1
- Authority
- AT
- Austria
- Prior art keywords
- bergamottin
- oral bioavailability
- pharmaceuticals
- increasing
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5612997P | 1997-08-19 | 1997-08-19 | |
PCT/US1998/016579 WO1999008676A1 (en) | 1997-08-19 | 1998-08-11 | Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE253357T1 true ATE253357T1 (de) | 2003-11-15 |
Family
ID=22002350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98939311T ATE253357T1 (de) | 1997-08-19 | 1998-08-11 | Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika |
Country Status (15)
Country | Link |
---|---|
US (1) | US6509371B1 (de) |
EP (1) | EP1007034B1 (de) |
JP (1) | JP2001515035A (de) |
KR (1) | KR100510809B1 (de) |
AT (1) | ATE253357T1 (de) |
AU (1) | AU747051B2 (de) |
BR (1) | BR9812131A (de) |
CA (1) | CA2291233C (de) |
DE (1) | DE69819519T2 (de) |
DK (1) | DK1007034T3 (de) |
ES (1) | ES2209184T3 (de) |
NZ (1) | NZ502668A (de) |
PT (1) | PT1007034E (de) |
WO (1) | WO1999008676A1 (de) |
ZA (1) | ZA987436B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1014575A3 (fr) * | 2002-01-16 | 2004-01-13 | Chapelle Andre | Composition a base de 5,7 dmc et/ou de bergamottine. |
US7169763B2 (en) * | 2002-02-22 | 2007-01-30 | Oliver Yoa-Pu Hu | Cytochrome P450 3A inhibitors and enhancers |
EP1847266B1 (de) | 2005-01-21 | 2013-12-25 | ARKRAY, Inc. | Stoffwechselsyndrom verbesserndes agens und medizin, ergänzungsstoff, funktionelles lebensmittel und lebensmittelzusatz damit |
JP4902964B2 (ja) * | 2005-03-30 | 2012-03-21 | 株式会社ファンケル | 薬物の代謝阻害剤とその使用 |
JP6387400B2 (ja) | 2013-05-30 | 2018-09-05 | ナノビオティックスNanobiotix | 医薬組成物、その製造および使用 |
DK3229776T3 (da) | 2014-11-25 | 2023-07-31 | Curadigm Sas | Farmaceutisk sammensætning, der kombinerer mindst to særskilte nanopartikler og en farmaceutisk forbindelse, fremstilling og anvendelser deraf |
DK3223796T3 (da) * | 2014-11-25 | 2021-09-27 | Curadigm Sas | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf |
KR101729494B1 (ko) | 2015-06-29 | 2017-04-25 | 제주대학교 산학협력단 | 6,7-디하이드록시 베르가모틴을 함유한 화장료 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2996838B2 (ja) * | 1993-07-12 | 2000-01-11 | 株式会社ポッカコーポレーション | 抗菌剤 |
US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
CA2224227A1 (en) | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5665386A (en) | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5716928A (en) | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
AU4821697A (en) * | 1996-10-18 | 1998-05-15 | Wayne State University | 6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice |
-
1998
- 1998-08-11 BR BR9812131-6A patent/BR9812131A/pt not_active Application Discontinuation
- 1998-08-11 EP EP98939311A patent/EP1007034B1/de not_active Expired - Lifetime
- 1998-08-11 PT PT98939311T patent/PT1007034E/pt unknown
- 1998-08-11 ES ES98939311T patent/ES2209184T3/es not_active Expired - Lifetime
- 1998-08-11 KR KR10-2000-7001649A patent/KR100510809B1/ko not_active IP Right Cessation
- 1998-08-11 WO PCT/US1998/016579 patent/WO1999008676A1/en active IP Right Grant
- 1998-08-11 JP JP2000509416A patent/JP2001515035A/ja not_active Abandoned
- 1998-08-11 US US09/486,117 patent/US6509371B1/en not_active Expired - Fee Related
- 1998-08-11 DK DK98939311T patent/DK1007034T3/da active
- 1998-08-11 NZ NZ502668A patent/NZ502668A/en unknown
- 1998-08-11 DE DE69819519T patent/DE69819519T2/de not_active Expired - Fee Related
- 1998-08-11 AT AT98939311T patent/ATE253357T1/de not_active IP Right Cessation
- 1998-08-11 CA CA002291233A patent/CA2291233C/en not_active Expired - Fee Related
- 1998-08-11 AU AU87770/98A patent/AU747051B2/en not_active Ceased
- 1998-08-18 ZA ZA987436A patent/ZA987436B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010023034A (ko) | 2001-03-26 |
PT1007034E (pt) | 2004-03-31 |
CA2291233C (en) | 2006-10-10 |
AU747051B2 (en) | 2002-05-09 |
ES2209184T3 (es) | 2004-06-16 |
BR9812131A (pt) | 2000-07-18 |
DE69819519T2 (de) | 2004-09-23 |
DE69819519D1 (de) | 2003-12-11 |
JP2001515035A (ja) | 2001-09-18 |
KR100510809B1 (ko) | 2005-08-31 |
AU8777098A (en) | 1999-03-08 |
WO1999008676A1 (en) | 1999-02-25 |
DK1007034T3 (da) | 2004-03-22 |
EP1007034B1 (de) | 2003-11-05 |
CA2291233A1 (en) | 1999-02-25 |
NZ502668A (en) | 2001-10-26 |
EP1007034A1 (de) | 2000-06-14 |
ZA987436B (en) | 1999-02-22 |
US6509371B1 (en) | 2003-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
SE0001899D0 (sv) | New compounds | |
ATE218341T1 (de) | Zwischenverbindungen von fortgeschrittenen glykosylierung-endprodukten und post-amadorische inhibitor | |
IT1312377B1 (it) | Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche | |
YU57600A (sh) | Derivarti biciklične hidroksaminske kiseline | |
GEP20053602B (en) | Aripiprazole for Oral Administration | |
HUP0201214A2 (en) | Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use | |
HUP0000838A2 (hu) | Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények | |
HUP0301941A2 (hu) | Tengeri állateredetż és növényi extraktumok kombinációját tartalmazó készítmények | |
ATE253357T1 (de) | Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika | |
FR2827774B1 (fr) | Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques | |
AU2030497A (en) | Propynyl or dienyl biaromatic compounds | |
AU5634500A (en) | Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis | |
AU2003271811A1 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
NO992998L (no) | Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse | |
AU2003246566A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
WO2001024803A3 (en) | Pharmaceutical compositions containing copper, salicylic acid and vitamines c | |
HUP9902421A2 (hu) | Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények | |
NZ512525A (en) | Skin whitening compositions for oral administration comprising a solvent extract from the plant of the genus Rosaceae Pyracantha | |
ATE301469T1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
ATE404519T1 (de) | Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen | |
HRP20040165B1 (en) | Citalopram for the treatment of elevated blood pressure | |
EP0955054A4 (de) | Aids-heilmittel | |
ATE334675T1 (de) | Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole | |
UA64074C2 (uk) | Кардіопротекторний антиоксидантний засіб "елгацин" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1007034 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |